| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 1191 |
| 1 | TIRZEPATIDE | 352 |
| 2 | GUSELKUMAB | 265 |
| 3 | ABATACEPT | 170 |
| 4 | INSULIN LISPRO | 125 |
| 5 | DUPILUMAB | 123 |
| 6 | ALBUTEROL SULFATE | 90 |
| 7 | ORAL SEMAGLUTIDE | 85 |
| 8 | UPADACITINIB | 67 |
| 9 | BELIMUMAB | 50 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COSIBELIMAB | 1 | 0.1429 |
| 1 | ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM | 2 | 0.0714 |
| 2 | ATORVALIQ | 1 | 0.0476 |
| 3 | NIVOLUMAB AND HYALURONIDASE-NVHY | 5 | 0.0368 |
| 4 | CEFTAZIDIME, AVIBACTAM | 4 | 0.0237 |
| 5 | NIVOLUMAB AND RELATLIMAB-RMBW | 8 | 0.0155 |
| 6 | INSULIN GLARGINE-AGLR | 1 | 0.0130 |
| 7 | REPOTRECTINIB | 3 | 0.0109 |
| 8 | NYSTATIN AND TRIAMCINOLONE ACETONIDE | 1 | 0.0095 |
| 9 | NYSTATIN, TRIAMCINOLONE ACETONIDE | 1 | 0.0092 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 35 | 0.0509 |
| 1 | Lymphocyte Activation Gene-3 Blocker [EPC] | 8 | 0.0155 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 20 | 0.0096 |
| 3 | Erythroid Maturation Agent [EPC] | 17 | 0.0065 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 21 | 0.0044 |
| 5 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 6 | Interleukin-23 Antagonist [EPC] | 322 | 0.0031 |
| 7 | Insulin Analog [EPC] | 1327 | 0.0030 |
| 8 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 9 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |